Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brought to you by:
ophthalmology
Biotech
UK biotech eyes $1B deal to deliver eye gene therapy at doctor
U.K. biotech Ikarovec has teamed up with VectorBuilder to work on an eye disease gene therapy that could be administered in a doctor’s office.
James Waldron
Jan 6, 2026 6:25am
Cash-strapped TME rethinks eye drug plan after losing partner
Jan 5, 2026 6:50am
Aldeyra dry eye disease decision hit by FDA delay
Dec 16, 2025 11:55am
Aviceda eye disease hopeful fails to top Astellas med in phase 2
Dec 15, 2025 2:14pm
Théa pens $280M deal for Iolyx's phase 3-ready eye disease drug
Dec 3, 2025 8:25am
Precise Bio completes 1st 3D-printed human cornea transplant
Nov 19, 2025 8:30am